Associate Professor Dan Siskind – Clozapine: A fine balance
Associate Professor Siskind trained as a psychiatrist in Australia and the United States. He graduated from medicine at The University of Queensland in 1998. After working with Doctors Without Borders in Chechnya in 2000, he became interested in psychiatry. He moved to Boston in 2002, where he did his psychiatry residency at Boston University and a Master of Public Health at Harvard University. He returned to Brisbane in June 2008 as a clinical academic psychiatrist at the Metro South Addiction and Mental Health Service. He completed his Ph.D in Feb 2014.
His research interests include clozapine and treatment refractory schizophrenia, the physical health of people with severe and persistent mental illness, supported accommodation, assertive community treatment and mental health services research. He was awarded an NHMRC Early Career Fellowship (2016-2019) looking at the cardio-metabolic health of people with severe and persistent mental illness.
He has over 150 peer reviewed publications, including first author in the The Lancet, BJPsych, Lancet Psychiatry, Diabetes Obesity and Metabolism, and ANZJP, as well as a Lancet Commission and publications in the BMJ and World Psychiatry, and has over $11 million in research grants.
About Seminar Series
The School of Pharmacy Seminar Series involves regular formal presentations of high-quality scholarly work with broad appeal.
The wider School community is invited to attend, including academic and professional staff, special guests, visitors, as well as HDR, postgraduate, masters and honours students.